Acquisition of blood, injury, and needle fears and phobias

doi:10.1016/0005-7967(94)90161-9

Behaviour Research and Therapy

Volume 32, Issue 8, November 1994, Pages 817-823

https://doi.org/10.1016/0005-7967(94)90161-9 Get rights and content

Abstract

The origins of fear and phobia of blood, injury, and injections were investigated in a sample of 128 fearful university students. Based on Mutilation Questionnaire scores, subjects were designated as common fear, high fear, or phobic. Ss reports of their onset experiences obtained from structured interviews were categorized into one or more acquisition pathways of conditioning, vicarious observation, and information. Of the 73% of Ss who recalled one or more onset experiences, 76% reported conditioning-like events as the primary pathway with the majority reporting fear-related UCSs. Vicarious experiences were reported as primary by 20% and 3% reported information as being primary in their fear onset. Severity of fear was unrelated to the pathway by which it was acquired, to whether the onset was recalled, and if recalled, whether it was due to a single or to multiple traumatic events. Results are discussed in terms of methodological problems of memory issues and means by which data are collected.

References (29)

P. DiNardo et al.
Etiology and maintenance of dog fears
Behaviour Research and Therapy
(1988)
S. Doogan et al.
Origins of fear of dogs in adults and children: the role of conditioning processes and prior familiarity with dogs
Behaviour Research and Therapy
(1992)
R.A. Kleinknecht et al.
Origins and characteristics of fear of dentistry
Journal of the American Dental Association
(1973)
R.A. Kleinknecht
Origins and remission of fear in a group of tarantula enthusiasts
Behaviour Research and Therapy
(1982)
R. Klorman et al.
Psychometric description of some specific-fear questionnaires
Behavior Therapy
(1974)
R. Menzies et al.
The etiology of fear of heights and its relationship to severity and individual response patterns
Behaviour Research and Therapy
(1993)
H. Merckelbach et al.
Pathways to spider phobia
Behaviour Research and Therapy
(1992)
H. Merckelbach et al.
Conditioning experiences in spider phobies
Behaviour Research and Therapy
(1991)
H. Merckelbach et al.
Conditioning experiences and phobias
Behaviour Research and Therapy
(1989)
E. Murray et al.
The origins of fear of snakes
Behaviour Research and Therapy
(1979)

T. Ollendick et al.

Origins of childhood fears: An evaluation of Rachman's theory of fear acquisition

Behaviour Research and Therapy

(1991)

L-G. Öst

Ways of acquiring phobias and outcome of behavioral treatments

Behaviour Research and Therapy

(1985)

L-G. Öst

Acquisition of blood and injection phobia and anxiety response patterns in clinical patients

Behaviour Research and Therapy

(1991)

L-G. Öst et al.

Acquisition of blood and dental phobia and anxiety response patterns in clinical patients

Behaviour Research and Therapy

(1985)

Cited by (64)

Trypanophobia among medical students - An overlooked concern
2023, Clinical Epidemiology and Global Health
Trypanophobia or needle phobia is a concern for many when it comes to vaccinations, injectable medicines, blood draws, donations and thus can form a basis of avoidance of certain procedures in healthcare professionals. Our study thus, aims to assess the proportion and risk factors associated with Trypanophobia among medical undergraduates.
The protocol was presented to approved by the Institutional Ethics Committee (IEC) and permission from the college authorities was obtained. An online questionnaire was developed and the link to the google form was circulated among all the students studying at the college. Responses were compiled, analysed and then reported. The Injection Phobia Scale – Anxiety, an 18 point questionnaire was used to assess the degree of anxiety experienced by students in stressful situations due to their needle phobia.
The mean age of the study participants was 19.6 ± 1.2 years (17–24 years) and 179 (35.7%) were males. Trypanophobia was seen in 155 (30.9%) students and 115 (35.7%) were females (p = 0.002). 282 (56.3%) students thought that such a fear should not be seen students in the health care setting. Anxiety was the symptom seen in the majority and the degree of anxiety was higher in situations involving contact with needles. Distraction was the most common coping mechanism.
More than one quarter of the respondents had Trypanophobia with majority being females. The degree of anxiety experienced by the students with Trypanophobia increased with the increase in the invasiveness of the procedure.
Effects of repeated exposure to fearful and disgusting stimuli on fear renewal in blood-injection-injury phobia
2020, Journal of Anxiety Disorders
Although exposure is effective for blood-injection-injury (BII) phobia, fear often returns after treatment. While disgust has been implicated in BII phobia, its effects on fear renewal are unclear. To address this knowledge gap, the present study examined the effect of repeated video exposure to fearful and disgusting stimuli in multiple contexts on fear renewal in BII phobia. Individuals with BII phobia (N = 57) were randomized to Disgust-Specific Exposure (DSE) which included exposure to disgusting but threat-irrelevant stimuli (i.e., vomit), Fear-Specific Exposure (FSE) which included exposure to threat-relevant stimuli (i.e., injections), or General Negative Exposure (GNE) which included exposure designed to elicit negative affect (i.e., tornado) without being disgusting or threat-relevant. During session one, participants watched a pre- and post-exposure assessment injection video (“pre/post assessment”), and a novel injection video after exposure to assess renewal effects (“novel 1”). Participants came in one week later to rate the same videos, and a new injection video (“novel 2”). For week one outcomes, comparisons of covariate adjusted means indicated the fear-specific group reported significantly lower levels of anxiety than the general-negative group to the post-exposure and novel 1 stimulus. When presented with the post-exposure stimuli during week two, the disgust-specific and fear-specific groups reported significantly lower levels of anxiety than the general negative group. The fear-specific group also reported significantly lower levels of anxiety than the disgust-specific and general-negative groups when presented with novel 1 and novel 2 stimuli at week two. These findings suggest that repeated exposure to threat-relevant cues in multiple contexts does reduce the return of anxiety. However, repeated exposure to disgusting but threat irrelevant stimuli may also produce some therapeutic effects. The implications of the integration of disgust-relevant processes into exposure-based treatment of BII phobia are discussed.
Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents
2017, Vaccine
Vaccines incorporated into microneedle-based patch platforms offer advantages over conventional hypodermic injections. However, the success and clinical utility of these platforms will depend on its acceptance among stakeholders. Minimal focus has been placed on determining parents’ acceptability of microneedle-patch vaccines intended for paediatric use. This qualitative study probes the perceived acceptability of microneedle technology for paediatric vaccination in a parent population.
Focus groups (n = 6) were convened through purposive sampling of Cork city primary schools. Discussions were audio-recorded, transcribed verbatim, anonymised, independently verified and analysed by thematic analysis, with constant comparison method applied throughout.
The opinions of 32 parents were included. All participants declared that their children were fully vaccinated. Five core themes were identified and defined as: (i) concern, (ii) suitability for paediatric use, (iii) potential for parental administration, (iv) the role of the healthcare professional and (v) special populations. Drivers for acceptance include; concerns with current vaccines and vaccination programmes; attributes of microneedle-patch (reduced pain, bleeding, fear and increased convenience) and endorsement by a healthcare professional. Barriers to acceptance include; lack of familiarity, concerns regarding feasibility and suitability in paediatrics, allergic potential, inability to confirm delivery and potential reduction in vaccine coverage.
This is the first study to explore parental acceptance of microneedle-patch vaccines. Capturing the opinions of parents, the ultimate decision makers in paediatric vaccination, is crucial in the understanding of the eventual uptake of microneedle technology and therefore adds to literature currently available. This study has revealed that even “vaccine-acceptors”; parents who agree with, or do not question vaccination, will question the safety and efficacy of this novel method. Participants in this study remained tentative. However, the study has also revealed that endorsement by healthcare professionals could reduce this tentativeness, thereby identifying the role of healthcare professionals in disseminating information and providing support to parents. An increased awareness of developments in microneedle technology is needed to permit informed decision-making by parents.
Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use
2016, Vaccine
To examine published research which explores the perception and acceptability of microneedle technology for immunisation and to investigate the suitability of this technology for paediatric use.
A series of keywords and their synonyms were combined in various combinations and permutations using Boolean operators to sequentially search four databases (PubMed, Web of Science, Embase and CINAHL). Following removal of duplications and irrelevant results, 12 research articles were included in the final literature review.
The opinions of patients, parents, children and healthcare professionals (HCP) were collated. A positive perception and a high level of acceptability predominated.
Microneedle technology research has been focussed on demonstrating efficacy with minimal focus on determining HCP/public perception and acceptability for paediatric use, exemplified by the paucity of studies presented in this review. Commercial viability will depend on HCP/public acceptability of microneedle technology. An effort must be made to identify the barriers to acceptance and to overcome them by increasing awareness and education in stakeholder groups pertaining to the paediatric population.
Approaching blood phobia and its different research lines
2014, Clinica y Salud
La hematofobia se podría definir por la presencia de miedo y una serie de conductas de evitación y/o escape ante lugares, objetos y situaciones relacionadas con la visión de sangre, agujas y heridas, existiendo un historial de desmayos en casi el 80% de los casos. Esta fobia tiene una prevalencia de 31‰ y genera un gran impacto en la vida del individuo. En el presente trabajo se han revisado las investigaciones más relevantes que han abordado tanto las distintas variables que pueden explicar el problema como los desmayos, junto con los tratamientos que han demostrado mayor eficacia en el campo. Para ello, se han agrupado los diversos estudios en tres líneas de investigación: la sensibilidad al asco, el rol de la hiperventilación y el sesgo atencional. Asimismo, también se han revisado los procedimientos de mayor eficacia probada en el campo. Los resultados obtenidos a través de la revisión apuntan que no hay diferencias significativas en cuanto a la eficacia de la tensión aplicada (TA) y la exposición (E) por sí sola, siendo estas técnicas las más eficaces para trabajar esta fobia. Respecto a las vías de investigación, en los últimos años las más significativas han sido la hiperventilación y el sesgo atencional. Finalmente, se proponen una serie de directrices encaminadas a orientar el tratamiento de estos pacientes en relación con estos resultados.
Blood phobia could be defined by the presence of fear and a number of avoiding or escaping behaviors regarding places, objects and situations related to the sight of blood, needles or injuries, with nearly an 80% of cases having a history of fainting. This phobia has a prevalence of 31‰ and usually implies a great impact on the subject's life. The present study is a review of the most outstanding literature in the field, addressing the explanatory variables along with the most effective treatments. Then, literature has been searched along three research lines: sensitivity to disgust, the role of hyperventilation, and the attentional bias. Also, the most effective procedures in the field have being reviewed. The results show that there is not a significant difference between the Applied Tension (AT) and the Exposure (E) alone – the most efficient techniques to treat this phobia. Regarding the three research lines mentioned above, the more significant procedures used over the last few years have been the role of hyperventilation and the attentional bias. Finally, a set of guidelines to work with these patients are put forward regarding these findings.
Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
2014, Journal of Controlled Release
Prophylaxis against influenza could be improved by the development of a stable, easy to deliver, potent mucosal vaccine. In this study, we spray-freeze-dried (SFD) whole inactivated virus influenza vaccine (WIV) alone or supplemented with monophosphoryl lipid A (MPLA) using inulin as a lyoprotectant. Physical characterization revealed that the SFD powder consisted of highly porous particles with a size distribution suitable for pulmonary administration. The receptor-binding properties of WIV and the immunostimulatory properties of MPLA were preserved after spray-freeze-drying as indicated by unchanged hemagglutination titers and a retained ability of the vaccine to activate NFkB after incubation with a reporter cell line, respectively. Pulmonary vaccination of mice with MPLA-adjuvanted liquid or powder WIV resulted in induction of higher mucosal and systemic antibody concentrations than vaccination with non-adjuvanted formulations. When exposed to influenza virus, mice immunized with MPLA-adjuvanted pulmonary vaccine showed similar protection in terms of reduction in lung virus titers and prevention of weight loss as mice immunized intramuscularly with subunit vaccine. Characterization of the antibody response revealed a balanced IgG2a-to-IgG1 profile along with induction of both memory IgA- and IgG-producing B cells in mice immunized with MPLA-adjuvanted vaccine. These studies suggest that the mucosal and systemic immune responses to pulmonary delivered influenza vaccines can be significantly enhanced by using MPLA as adjuvant. MPLA-adjuvanted SFD vaccine was particularly effective implying that delivery of adjuvanted vaccine powder to the lungs can be an attractive way of immunization against influenza.

View all citing articles on Scopus

View full text

Acquisition of blood, injury, and needle fears and phobias

Abstract

Behaviour Research and Therapy

Behaviour Research and Therapy

Journal of the American Dental Association

Behaviour Research and Therapy

Behavior Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy

Behaviour Research and Therapy